💬 Perspective: Regulatory frameworks for autonomous clinical #AI require ongoing competency and performance monitoring; licensure models offer a safer, flexible alternative to FDA device approval. ja.ma/3Raua6M

😅😂

By demanding the release of the Epstein files, Democrats have embraced a radically new way of fighting Donald Trump. Is that a good thing? www.newyorker.com/news/the-pol...

Blogging and writing style statmodeling.stat.columbia.edu/2026/04/25/b...

🩺📚 Learn more this week about suicide prevention and artificial intelligence. ➡️ www.cmaj.ca/lookup/doi/10.1503/cmaj.251693

Still ordering hydralazine? 🤔 Beyond case reports, this large cohort compares hydralazine vs ACEi/ARB to estimate real-world vasculitis risk, will this 📉 bias & clarify the answer Read more 👇 pubmed.ncbi.nlm.nih.... #TenPostNephJC #NephJC #NephSky #MedSky

Vancouver designer John Fluevog creates shoe to honour kidney donor | Globalnews.ca - goo.gl/alerts/ShFS9x #GoogleAlerts

#NephJC and @theisn.org Advancing Clinical Trials collab for #Nephtrials STEPS trial tests coordinated system-level intervention to improve preemptive kidney transplant 🗓️XSpce: April 10, 12pm EST ✍️Blog by @dramiliflores.bsky.social and @nephroseeker.medsky.social www.nephjc.com/news/steps-n...

How a simple question could help reduce youth homelessness. New programs aim to divert youth away from shelters by reconnecting them with a loved one, by @erinanderssen.bsky.social www.theglobeandmail.com/life/article... via @theglobeandmail.com

IN A FEW WORDS essay by Jonathan S. Pollack: The Roller Coaster Ride of IgA Nephropathy bit.ly/4vFDAas (FREE)

Physical activity and appropriate sleep linked to subsequent lower dementia risk medicalxpress.com/news/2026-04... #Alzheimers #dementia #health #wellness #sleep #exercise #fitness

Reports of dignity’s death as a useful bioethics concept were greatly exaggerated. It does real work — precisely because it unsettles the dust that cleaner operational constructs leave behind. #bioethics

📢 The FDA has approved the first ever treatment for FSGS, supported by the PARASOL initiative. RaDaR contributed as an external validation cohort, highlighting the power of global collaboration & patient data. 📰: https://ow.ly/IJNH50YJXBB #RareDisease #KidneyResearch #FSGS

Ontario overhauls MAID oversight committee, critics say it's to remove dissenters https://www.theglobeandmail.com/canada/article-ontario-overhauls-maid-oversight-committee-critics-say-its-to-remove/ ⦸ ↷ canadahealthwatch.ca/featured 🍁

Self-Measured Home Orthostatic Hypo- and Hypertension—Prevalence and Associations With Atherosclerosis and Arterial Stiffness academic.oup.com/ajh/article/... #OpenAccess

Editorial commentary Orthostatic Hypertension, an Easy to Detect Cardiovascular Prognostic Marker That Cannot be Neglected academic.oup.com/ajh/article-... Original research: academic.oup.com/ajh/article/...

Freely Filtered for Liberate-D just dropped! We had a great time talking with some of the study authors and learning why we should be saying “No” more frequently @hswapnil.medsky.social @captainchloride.bsky.social

#HotOffThePress academic.oup.com/ajh/advance-... Nighttime Central Blood Pressure and Left Ventricular Hypertrophy in Non-Dialysis CKD: A Multicenter Study

The New York Times Got Played By A Telehealth Scam And Called It The Future Of AI Since the New York Times published its semi-viral big profile of Medvi last week — the "AI-powered" telehealth startup that it breathlessly described as a "$1.8 billion company" supposedly run by just two brothers —…

Happening tomorrow! @lonniepyne.bsky.social from McMaster will present on eGFR changes as outcomes of interest #NephGR #NephSky

Regulation is not keeping up with peptide therapy. And there are still major gaps in the evidence about whether peptides' anti-aging claims stack up, and whether they are safe for humans. www.sciencealert.com/injectable-p...

Learn more about C3G Treatment in this #NephMadness commentary by @saynanorouzi.bsky.social and Saloni Gupta on the #AJKDBlog: C3G Treatment–The Ultimate Glow-Up Story bit.ly/NM26NorouziG...

11/10 Like what you see 👀 Want to join a fun team of FOAMed enthusiasts? Want to learn more about VAs, Blogs and Podcasts (oh my)! Applications now open: www.nephjc.com/news/nephjc-editorial-internship This has been @brianrifkin.bsky.social with a NEW 10 POSTS ✍️

10/10 Final thoughts 🧂Don't be salty, sometimes doing nothing isn't wrong. ➡️Up next- 4/10/26: NephTrials System Interventions to Achieve Early and Equitable Kidney Transplants (STEPS): protocol (www.pubmed.ncbi.nlm.nih.gov/40199386/) More at www.nephjc.com/

9/10 I want more info: He’s here, he’s there he’s every f-ing where Roy Ken..I mean @brianrifkin.bsky.social with the VA and blog: www.nephjc.com/news/hyponatremia/hit-trial www.nephjc.com/news/2026/4/4/hyponatremia-correction-the-visual-abstract

7/10 Question 2/3 #NephJC #NephSky 2. Do you think if strategies were followed longer (60 days post hospitalization) that the outcomes may have been different? 3. Would you want to see an exclusively outpatient, protocol driven intervention with outcomes?

6/10 Question 1 #NephJC #NephSky 1. What is your treatment of choice for a hospitalized, asymptomatic mildly hyponatremia (128-134 mmol/L) euvolemic pt? a. nothing b. fluid restriction c. urea d. vaptan e. other

3/10 1 post methods This is a pragmatic, RCT, parallel-group, multi-center superiority trial with blinded outcome assessment. Conducted at 9 centers in Europe from 8/2018-4/2024. University & community based hospitals were included. (Sorry, can’t resist a good Na joke)

1/10 #TenPostNephJC #NephSky What do you do with a consult for a hospitalized pt with Na = 131? “Just chill” 🥶or “Guns a blazin’” 🤠(fluid restrict, urea, vaptan)? Do these strategies improve mortality or re-hospitalization? Read the article 👇 pubmed.ncbi.nlm.nih.gov/41733398/

0/10 Hey NephJC faithful, we are shaking it up. Given the 📉 attendance at live chats we’re changing to a summary 🧵& ❓ to answer, at your convenience. Still tag us #NephJC to get the discussion going! PS If we hear enough comments, we might bring chats back!😉

Finally FDA ✔️ Farxiga generics Time to accelerate #Flozination in the US

Hey #NephSky #MedSky 📣If you were planning on coming to the #NephJC chat on hyponatremia 4/7/26 at 9 pm...relax, we're trying something new (and it will be on Twitter and BlueSky)! www.nephjc.com/news/2026/4/7/regarding-the-situation-withsocial-media-in-general

5/ #NephJC covering all the simultaneous LBCT publications was a stretch- even beyond the jet lag. Teamwork made it possible. The goal stayed simple: bring those at home closer and make them part of the #ISNWCN vibe @hswapnil.medsky.social @brianrifkin.bsky.social www.nephjc.com/news/isnwcn-...

🧂Hyponatremia. We see it. We fix it. #NephJC But what if fixing the sodium… doesn’t fix the patient? The HIT trial challenges one of medicine’s most reflexive moves ✍️ By @brianrifkin.bsky.social www.nephjc.com/news/hyponat...

#NephMadness 2026: The Filtered Four Check out the 2nd round results on the #AJKDBlog: bit.ly/NM26Filtered4 @nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social @ssfarouk.bsky.social

Left and Right Kidney results will be revealed on April 8! Until then, check out the current #NephMadness 2026 Bracket and read the Blue Ribbon Panel comments defending their picks: bit.ly/NM26Filtered4

And what-if scenarios are live Interesting - @brianrifkin.bsky.social you may have a chance to make it! #NephMadness www.tourneytopia.com/AJKD/NephMad...

As the #Filtered4 drop ajkdblog.org/2026/04/06/n... #NephMadness More news about why the B-Cell juggernaut will be the eventual champion: www.kireports.org/article/S246... in @kireports.bsky.social on zigakibart

Proposed cuts of $5 billion in NIH funding and $129 million to the Agency for Healthcare Research and Quality (AHRQ) were included in the Trump administration's fiscal year 2027 budget. www.medpagetoday.com/publichealth...

Do you have #FOMO from missing all the fun at #ISNWCN ? We've got you covered!! Check out the interview with @nephroseeker.medsky.social and @hswapnil.medsky.social discussing simultaneous publications at WCN in Yokohama, Japan #NephSky www.nephjc.com/news/conf-coverage

There's a lot more to "Take Me Out to the Ball Game" than "peanuts and Cracker Jack." n.pr/3O7nPYG

#NephMadness 2026: The Effluent Eight bit.ly/NM26Eff8 @nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social @ssfarouk.bsky.social

#NephMadness 2026: The Effluent Eight Here are the first round results: bit.ly/NM26Eff8 @nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @jrkott27.bsky.social @catochita.bsky.social @ssfarouk.bsky.social

Here is the current #NephMadness 2026 Bracket! Read all comments from the Blue Ribbon Panel here: bit.ly/NM26Eff8

Turns out the phase 3 trial of posoleucel for BK was stopped by the company with no plans for future development. This wasn’t mentioned in the write ups. 🤷🏻‍♀️ Clinicaltrials.gov/study/NCT05305040

A judge has dismissed a legal challenge aimed at forcing Elsevier to retract a long-criticized study that concluded the antidepressant Paxil was safe and effective for teens.

FDA asks Amgen (which bought Chemocentryx) for voluntary withdrawal of Avacopan From January, with fresh Medscape coverage Amgen www.amgen.com/tavneos-pres... Medscape www.medscape.com/s/viewarticl... - liver concerns - BVAS scoring discrepancy from ADVOCATE

As @kidneyboy.bsky.social sez (on the other site) given limited efficacy benefit anyways - #avacopan is now dead until proven otherwise Stop using it

@nephroninja.bsky.social for SGLT2i question - see pubmed.ncbi.nlm.nih.gov/41177216/ in @ajkd.bsky.social for the mediation analysis from EMPAKIDNEY It is ~ 15% Clearly there is something else too given it is beneficial in nonalbuminuric CKD (eg GFR slope from Empakidney or the CV outcome RCTs)